Produkty 26490-31-3

CAS 26490-31-3 występuje w naszej ofercie pod nazwami: Nandrolone 17beta-Laurate, >95% (HPLC), Nandrolone laurate, Nandrolone laurate. Oferty producentów: TRC, GLPBio, Biosynth. Dostępne opakowania: 100mg, 250mg, 25mg, 10mg, 5mg, 50mg.

Nandrolone 17beta-Laurate, >95% (HPLC)
TRC
  • opakowanie: 100mg, 250mg, 25mg
  • Warianty: 3
Zobacz produkt
Nandrolone laurate
GLPBio
  • opakowanie: 10mg, 25mg, 5mg, 50mg
  • Warianty: 4
od 1678,24
Zobacz produkt
Nandrolone laurate
Biosynth
  • opakowanie: 250mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] dodecanoate (CAS 26490-31-3) to związek chemiczny o wzorze sumarycznym C30H48O3 i masie molowej 456.7 g/mol. Nazwa systematyczna IUPAC: [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] dodecanoate. InChIKey: OXXNTXVXBWLYQE-PVHICTMWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H48O3
Masa molowa456.7 g/mol
Nazwa IUPAC[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] dodecanoate
InChIKeyOXXNTXVXBWLYQE-PVHICTMWSA-N
SMILESCCCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Nandrolone laurate, Nandrolone dodecanoate, Laurabolin V, LAURABOLIN, 3-Oxo-4-estren-17beta-laurat, Laurabolin [veterinary] (TN), NANDROLONE DODECANOATE [MI], NANDROLONE DECANOATE IMPURITY I [EP IMPURITY], NANDROLONE DECANOATE IMPURITY I (EP IMPURITY), Laurabolin (veterinary)
Izomery (ten sam wzór sumaryczny)
(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O3
(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid C30H48O3
(3R,4R,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid C30H48O3
[(8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate C30H48O3
(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid C30H48O3
(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid C30H48O3
(4aS,6aR,6aS,6bR,8aR,10R,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O3
(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10,11,11-trideuterio-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,12,13,14b-dodecahydropicene-4a-carboxylic acid C30H48O3
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate C30H48O3